| 91
VEIT, LINDA J., ACS Clinical Research Program: Limited resection as a cure for early lung cancer: Time to
challenge the gold standard? 100, 5: 57
–and BOUGHEY, JUDY C., and NELSON, HEIDI, and
HUNT, KELLY, K., and MARTIN, LINDA W., and
VEERAMACHANENI, NIRMAL K., and KATZ,
MATTHEW H. G., ACS Clinical Research Program:
New manual for cancer surgery issued: Operative Standards for Cancer Surgery, 100, 6: 43
–and BOUGHEY, JUDY C., and ROSES, ROBERT E.,
and DATTA, JASHODEEP, ACS Clinical Research
Program: Multimodality treatment considerations in
esophageal and gastric cancer: Are we making progress? 100, 7: 63
–and BOUGHEY, JUDY C., and ZELL, JASON, ACS
Clinical Research Program: PACES trial: Evaluating the
effectiveness of eflornithine and sulindac in preventing
colon adenomas, 100, 8: 70
–and KROUSE, ROBERT S., ACS Clinical Research Pro-
gram: Prospective comparative effectiveness trial for
malignant bowel obstruction: S WOG S1316, 100, 12: 49
–and WEISER, MARTIN R., and FICHERA, ALESSAN-
DRO, and SCHRAG, DEBORAH, and BOUGHEY,
JUDY C., ACS Clinical Research Program: Progress
in the PROSPECT trial: Precision treatment for rectal
cancer? 100, 4: 51
Z
ZELL, JASON, and YOU, Y. NANCY, and BOUGHEY,
JUDY C., ACS Clinical Research Program: PACES trial:
Evaluating the effectiveness of eflornithine and sulindac
in preventing colon adenomas, 100, 8: 70
